skip to search skip to navigation skip to main content

Archive: December 2016

Astellas Announces Transfer of Qutenza™ to Grünenthal

13th December 2016 in Mergers & Acquisitions

TOKYO and CHERTSEY – 12 December, 2016: Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”), today announced that Astellas Pharma Europe Ltd. (“Astellas Pharma Europe”) has entered into a definitive agreement with Grünenthal under which Astellas Pharma Europe will transfer the exclusive rights for Qutenza™ (capsaicin 8% patch) in Europe, Middle East and Africa…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2018 Astellas Pharma